日本語フィールド
著者：*Kosuke Saita, Masahiko Sumitani, Daisuke Nishizawa, Takashi Tamura, Kazutaka Ikeda, Kenji Wakai, Yoshika Sudo, Hiroaki Abe, Jun Otonari, Hiroaki Ikezaki, Kenji Takeuchi, Asahi Hishida, Keitaro Tanaka, Chisato Shimanoe, Toshiro Takezaki, Rie Ibusuki, Isao Oze, Hidemi Ito, Etsuko Ozaki, Daisuke Matsui, Yohko Nakamura, Miho Kusakabe, Sadao Suzuki, Hiroko Nakagawa-Senda, Kokichi Arisawa, Sakurako Katsuura-Kamano, Kiyonori Kuriki, Yoshikuni Kita, Yasuyuki Nakamura, Yukihide Momozawa, Kanji Uchida題名：Genetic polymorphism of pleiotrophin is associated with pain experience in Japanese adults: Case-control study 発表情報：Medicine (Baltimore) 巻: 101 号: 37 ページ: e30580キーワード：概要：Genetic factors play a role in individual differences in pain experience. Here, we performed a genome-wide association study (GWAS) to identify novel loci regulating pain processing. We conducted a 2-stage GWAS and the candidate single-nucleotide polymorphisms (SNPs) association study on pain experience using an exploratory cohort of patients with cancer pain. The confirmatory cohort comprised of participants from the general population with and without habitual use of analgesic medication. In the exploratory cohort, we evaluated pain intensity using a numerical rating scale, recorded daily opioid dosages, and calculated pain reduction rate. In the confirmatory cohort, pain experience was defined as habitual nonsteroidal anti-inflammatory drug usage. Using linear regression models, we identified candidate SNP in the exploratory samples, and tested the association between phenotype and experienced pain in the confirmatory samples. We found 1 novel SNP (rs11764598)-located on the gene encoding for pleiotrophin on chromosome 7-that passed the genome-wide suggestive significance at 20% false discovery rate (FDR) correction in the exploratory samples of patients with cancer pain (P = 1.31 × 10-7, FDR = 0.101). We confirmed its significant association with daily analgesic usage in the confirmatory cohort (P = .028), although the minor allele affected pain experience in an opposite manner. We identified a novel genetic variant associated with pain experience. Further studies are required to validate the role of pleiotrophin in pain processing. 抄録：英語フィールド
Author：*Kosuke Saita, Masahiko Sumitani, Daisuke Nishizawa, Takashi Tamura, Kazutaka Ikeda, Kenji Wakai, Yoshika Sudo, Hiroaki Abe, Jun Otonari, Hiroaki Ikezaki, Kenji Takeuchi, Asahi Hishida, Keitaro Tanaka, Chisato Shimanoe, Toshiro Takezaki, Rie Ibusuki, Isao Oze, Hidemi Ito, Etsuko Ozaki, Daisuke Matsui, Yohko Nakamura, Miho Kusakabe, Sadao Suzuki, Hiroko Nakagawa-Senda, Kokichi Arisawa, Sakurako Katsuura-Kamano, Kiyonori Kuriki, Yoshikuni Kita, Yasuyuki Nakamura, Yukihide Momozawa, Kanji UchidaTitle：Genetic polymorphism of pleiotrophin is associated with pain experience in Japanese adults: Case-control study Announcement information:Medicine (Baltimore) Vol: 101 Issue: 37 Page: e30580An abstract：Genetic factors play a role in individual differences in pain experience. Here, we performed a genome-wide association study (GWAS) to identify novel loci regulating pain processing. We conducted a 2-stage GWAS and the candidate single-nucleotide polymorphisms (SNPs) association study on pain experience using an exploratory cohort of patients with cancer pain. The confirmatory cohort comprised of participants from the general population with and without habitual use of analgesic medication. In the exploratory cohort, we evaluated pain intensity using a numerical rating scale, recorded daily opioid dosages, and calculated pain reduction rate. In the confirmatory cohort, pain experience was defined as habitual nonsteroidal anti-inflammatory drug usage. Using linear regression models, we identified candidate SNP in the exploratory samples, and tested the association between phenotype and experienced pain in the confirmatory samples. We found 1 novel SNP (rs11764598)-located on the gene encoding for pleiotrophin on chromosome 7-that passed the genome-wide suggestive significance at 20% false discovery rate (FDR) correction in the exploratory samples of patients with cancer pain (P = 1.31 × 10-7, FDR = 0.101). We confirmed its significant association with daily analgesic usage in the confirmatory cohort (P = .028), although the minor allele affected pain experience in an opposite manner. We identified a novel genetic variant associated with pain experience. Further studies are required to validate the role of pleiotrophin in pain processing. 